BX · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $14.45B | $13.23B | $8.02B | $8.52B | $22.58B | $6.10B | $7.34B | $6.83B |
| Selling, General & Administrative | $1.52B | $1.36B | $1.12B | $1.09B | $917.85M | $711.78M | $679.41M | $594.87M |
| Operating Expenses | $7.70B | $6.82B | $4.98B | $4.97B | $9.48B | $3.48B | $3.96B | $3.51B |
| Interest Expense | $508.31M | $443.69M | $431.87M | $317.23M | $198.27M | $166.16M | $199.65M | $163.99M |
| Other Income / (Expense) | $423.99M | $48.84M | -$84.00M | -$82.86M | $458.87M | -$4.84M | $444.40M | $191.72M |
| Income Before Taxes | $7.17B | $6.46B | $2.96B | $3.46B | $13.56B | $2.62B | $3.82B | $3.51B |
| Provision for Income Taxes | $1.13B | $1.02B | $513.46M | $472.88M | $1.18B | $356.01M | -$47.95M | $249.39M |
| Net Income | $3.02B | $2.78B | $1.39B | $1.75B | $5.86B | $1.05B | $2.05B | $1.54B |
| Basic EPS | $3.87 | $3.62 | $1.84 | $2.36 | $8.14 | $1.50 | $3.03 | $2.27 |
| Diluted EPS | $3.87 | $3.62 | $1.84 | $2.36 | $8.13 | $1.50 | $3.03 | $2.26 |
| Basic Shares Outstanding | 780.02M | 766.49M | 755.20M | 740.66M | 719.77M | 696.93M | 675.90M | 678.85M |
| Diluted Shares Outstanding | 780.22M | 766.65M | 755.42M | 740.94M | 720.13M | 697.26M | 676.17M | 1.21B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $6.00 | $5.79 | $6.18 | 10 | ↑6 ↓3 |
| Dec 2027 | $7.58 | $6.86 | $8.17 | 10 | ↑3 ↓6 |
| Dec 2028 | $8.41 | $8.07 | $8.74 | 4 | ↑0 ↓0 |
| Dec 2029 | $9.89 | $9.61 | $10.17 | 2 | ↑1 ↓0 |